SEA: OTC pharma market revenue 2028

The revenue in the otc pharmaceuticals market in Southeast Asia was forecast to continuously increase between 2024 and 2028 by in total 2.7 billion U.S. dollars (+29.44 percent). After the seventh consecutive increasing year, the indicator is estimated to reach 11.89 billion U.S. dollars and therefore a new peak in 2028.

Revenue of the OTC pharmaceuticals market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars)

Characteristic	Revenue in billion U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

* Forecast

Data provided by Statista Market Insights are estimates.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Citation formats